The risk of diabetes and <scp>HbA1c</scp> deterioration during antipsychotic drug treatment: A <scp>Danish</scp> two‐cohort study among patients with first‐episode schizophrenia
This comprehensive real-world two-cohort study emphasizes that diabetes affects almost 10% of patients with FES. Antipsychotics increase this risk, while HbA1c deterioration requires longer treatment. These findings are important for clinicians and young patients with FES.
Authors
- Ole Köhler‐Forsberg (ORCID: https://orcid.org/0000-0001-5121-1287)
- Christopher Rohde (ORCID: https://orcid.org/0000-0001-9458-506X)
- Mikkel Højlund (ORCID: https://orcid.org/0000-0002-5786-5203)
- Andreas Aalkjær Danielsen (ORCID: https://orcid.org/0000-0002-6585-3616)
- Marc A. Sørensen
- Nanna M. Madsen
Institutions
- University of Southern Denmark (DK)
- Aarhus University (DK)
- Mental Health Services (DK)
- Aarhus University Hospital (DK)
- Region of Southern Denmark (DK)
- Capital Region of Denmark (DK)
Publication Details
- Journal
- Acta Psychiatrica Scandinavica
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1111/acps.13760
- Citations
- 3
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16